• Additive effects of eldecalcitol in poorly responding long-term bisphosphonate treatment for osteopo...

• Kamimura Mikio

• Ikegami Shota, Mukaiyama Keijiro, Koiwai Hidefumi, Nakamura Yukio, Taguchi Akira, Kato Hiroyuki

• Osteoporosis and Sarcopenia   2019  Volume.5  No.2 57 ~ 61

• Impact of patient background factors on the treatment efficacy of once-weekly teriparatide

• Omura Fumitoshi

• Osteoporosis and Sarcopenia   2019  Volume.5  No.2 51 ~ 56

• Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteopo...

• Ifuku Emiko

• Yoshimura Takeshi, Uzawa Toyonobu, Hokonohara Tadami

• Osteoporosis and Sarcopenia   2019  Volume.5  No.2 44 ~ 50

• The incidence of hip fracture and mortality rate after hip fracture in Korea: A nationwide populatio...

• Hong Sang-Mo

• Han Kyung-Do

• Osteoporosis and Sarcopenia   2019  Volume.5  No.2 38 ~ 43

• Diabetes and bone

• Hygum Katrine

• Starup-Linde Jakob, Langdahl Bente L.

• Osteoporosis and Sarcopenia   2019  Volume.5  No.2 29 ~ 37

• How different is the once-weekly teriparatide from the daily one or the same?

• Takeuchi Yasuhiro

• Osteoporosis and Sarcopenia   2019  Volume.5  No.2 27 ~ 28